E-LIB Suche - Ergebnisse für: Bewersdorf, Jan

1

P489: PROGNOSTIC IMPACT OF "MULTI-HIT" VERSUS "SINGLE-HIT" ..:

Badar, Talha ; Atallah, Ehab ; Shallis, Rory M....
HemaSphere. 7 (2023) S3 - p. e429374f , 2023

Link: https://doi.org/10.1097/..

2

P1030: SPLEEN VOLUME REDUCTION PREDICTS SURVIVAL IN MYELOFI..:

Bewersdorf, Jan ; Ajufo, Helen ; Harrison, Claire...
HemaSphere. 7 (2023) S3 - p. e44640da , 2023

Link: https://doi.org/10.1097/..

3

S170: MYELODYSPLASTIC NEOPLASMS (MDS) CLASSIFICATION FROM W..:

Komrokji, Rami S. ; Ball, Somdeb ; Maggioni, Giulia...
HemaSphere. 7 (2023) S3 - p. e616260d , 2023

Link: https://doi.org/10.1097/..

4

P745: MULTI-CENTER PHASE IB TRIAL OF THE HISTONE DEACTYLASE..:

Bewersdorf, Jan ; M. Shallis, Rory ; Sharon, Elad...
HemaSphere. 7 (2023) S3 - p. e30347e2 , 2023

Link: https://doi.org/10.1097/..

5

Vascular Endothelial Growth Factor: A Novel Endocrine Defen..:

Dantz, Dorle ; Bewersdorf, Jan ; Fruehwald-Schultes, Bernd...
The Journal of Clinical Endocrinology & Metabolism. 87 (2002) 2 - p. 835-840 , 2002

Link: https://doi.org/10.1210/..

6

Combination therapy with hypomethylating agents and venetoc..:

Bewersdorf, Jan Philipp ; Shimony, Shai ; Shallis, Rory M....
American Journal of Hematology. , 2024

Link: https://doi.org/10.1002/..

7

Comparing venetoclax in combination with hypomethylating ag..:

Badar, Talha ; Nanaa, Ahmad ; Atallah, Ehab...
Blood Cancer Journal. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

8

Integrated genetic, epigenetic, and immune landscape of TP5..:

Zeidan, Amer M. ; Bewersdorf, Jan Philipp ; Hasle, Vanessa...
Therapeutic Advances in Hematology. 15 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

9

Hypomethylating agents plus venetoclax compared with intens..:

Shimony, Shai ; Bewersdorf, Jan Philipp ; Shallis, Rory M....
Leukemia. 38 (2024) 4 - p. 762-768 , 2024

Link: https://doi.org/10.1038/..

10

Prognostic impact of 'multi-hit' versus 'single hit' TP53 a..:

Badar, Talha ; Nanaa, Ahmad ; Atallah, Ehab...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

11

Toward a more patient‐centered drug development process in ..:

Efficace, Fabio ; Buckstein, Rena ; Abel, Gregory A....
HemaSphere. 8 (2024) 5 - p. , 2024

Link: https://doi.org/10.1002/..

12

Correction to: Treatment of Myelodysplastic Syndromes for O..:

Kewan, Tariq ; Stahl, Maximillian ; Bewersdorf, Jan Philipp.
Current Hematologic Malignancy Reports. 19 (2024) 3 - p. 151-151 , 2024

Link: https://doi.org/10.1007/..

13

Treatment of Myelodysplastic Syndromes for Older Patients: ..:

Kewan, Tariq ; Stahl, Maximillian ; Bewersdorf, Jan Philipp.
Current Hematologic Malignancy Reports. 19 (2024) 3 - p. 138-150 , 2024

Link: https://doi.org/10.1007/..

14

What's Next after Hypomethylating Agents Failure in Myeloid..:

Awada, Hussein ; Gurnari, Carmelo ; Xie, Zhuoer..
Cancers. 15 (2023) 8 - p. 2248 , 2023

Link: https://doi.org/10.3390/..

15

When to use which molecular prognostic scoring system in th..:

Kewan, Tariq ; Bewersdorf, Jan Philipp ; Gurnari, Carmelo...
Best Practice & Research Clinical Haematology. 36 (2023) 4 - p. 101517 , 2023

Link: https://doi.org/10.1016/..